about
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines ...
Read More
3.04
0.04
(1.33%)
103.0K
XNAS Volume
XNAS 13 Mar, 2026 10:50 AM (EDT)
Board Meeting
The board meeting for AC Immune SA is scheduled for today, for the purpose of AC Immune SA Fourth Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
AC Immune SA Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..